|
1
|
Ando K, Heymann MF, Stresing V, Mori K,
Rédini F and Heymann D: Current therapeutic strategies and novel
approaches in osteosarcoma. Cancers (Basel). 5:591–616. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Isakoff MS, Bielack SS, Meltzer P and
Gorlick R: Osteosarcoma: Current treatment and a collaborative
pathway to success. J Clin Oncol. 33:3029–3035. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ottaviani G and Jaffe N: The epidemiology
of osteosarcoma. Cancer Treat Res. 152:3–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kong G, Qi XJ and Wang JF: Effect of
lncRNA LET on proliferation and invasion of osteosarcoma cells. Eur
Rev Med Pharmacol Sci. 22:1609–1614. 2018.PubMed/NCBI
|
|
5
|
Yan L, Wu X, Liu Y and Xian W: LncRNA
Linc00511 promotes osteosarcoma cell proliferation and migration
through sponging miR-765. J Cell Biochem. Dec 28–2018.(Epub ahead
of print).
|
|
6
|
Li X, Wu Z, Fu X and Han W: Long noncoding
RNAs: Insights from biological features and functions to diseases.
Med Res Rev. 33:517–553. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Rev Genet.
10:155–159. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shi D, Wu F, Mu S, Hu B, Zhong B, Gao F,
Qing X, Liu J, Zhang Z and Shao Z: LncRNA AFAP1-AS1 promotes
tumorigenesis and epithelial-mesenchymal transition of osteosarcoma
through RhoC/ROCK1/p38MAPK/Twist1 signaling pathway. J Exp Clin
Cancer Res. 38:3752019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jin Y, Feng SJ, Qiu S, Shao N and Zheng
JH: LncRNA MALAT1 promotes proliferation and metastasis in
epithelial ovarian cancer via the PI3K-AKT pathway. Eur Rev Med
Pharmacol Sci. 21:3176–3184. 2017.PubMed/NCBI
|
|
10
|
Liang H, Yu T, Han Y, Jiang H, Wang C, You
T, Zhao X, Shan H, Yang R, Yang L, et al: LncRNA PTAR promotes EMT
and invasion-metastasis in serous ovarian cancer by competitively
binding miR-101-3p to regulate ZEB1 expression. Mol Cancer.
17:1192018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Du Z, Fei T, Verhaak RG, Su Z, Zhang Y,
Brown M, Chen Y and Liu XS: Integrative genomic analyses reveal
clinically relevant long noncoding RNAs in human cancer. Nat Struct
Mol Biol. 20:908–913. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kong FR, Lv YH, Yao HM, Zhang HY, Zhou Y
and Liu SE: LncRNA PCAT6 promotes occurrence and development of
ovarian cancer by inhibiting PTEN. Eur Rev Med Pharmacol Sci.
23:8230–8238. 2019.PubMed/NCBI
|
|
13
|
Shi X, Liu Z, Liu Z, Feng X, Hua F, Hu X,
Wang B, Lu K and Nie F: Long noncoding RNA PCAT6 functions as an
oncogene by binding to EZH2 and suppressing LATS2 in non-small-cell
lung cancer. EBioMedicine. 37:177–187. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhu C, Huang L, Xu F, Li P, Li P and Hu F:
LncRNA PCAT6 promotes tumor progression in osteosarcoma via
activation of TGF-β pathway by sponging miR-185-5p. Biochem Biophys
Res Commun. 521:463–470. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Han R, Huang G, Wang Y, Xu Y, Hu Y, Jiang
W, Wang T, Xiao T and Zheng D: Increased gene expression noise in
human cancers is correlated with low p53 and immune activities as
well as late stage cancer. Oncotarget. 7:72011–72020. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sun X, Hu Y, Wu J, Shi L, Zhu L, Xi PW,
Wei JF and Ding Q: RBMS2 inhibits the proliferation by stabilizing
P21 mRNA in breast cancer. J Exp Clin Cancer Res. 37:2982018.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hou PF, Jiang T, Chen F, Shi PC, Li HQ,
Bai J and Song J: KIF4A facilitates cell proliferation via
induction of p21-mediated cell cycle progression and promotes
metastasis in colorectal cancer. Cell Death Dis. 9:4772018.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim EM, Jung CH, Kim J, Hwang SG, Park JK
and Um HD: The p53/p21 complex regulates cancer cell invasion and
apoptosis by targeting Bcl-2 family proteins. Cancer Res.
77:3092–3100. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Seipel K, Marques MAT, Sidler C, Mueller
BU and Pabst T: The cellular p53 inhibitor MDM2 and the growth
factor receptor FLT3 as biomarkers for treatment responses to the
MDM2-inhibitor idasanutlin and the MEK1 inhibitor cobimetinib in
acute myeloid leukemia. Cancers (Basel). 10:1702018. View Article : Google Scholar
|
|
20
|
Chen Y, Wang DD, Wu YP, Su D, Zhou TY, Gai
RH, Fu YY, Zheng L, He QJ, Zhu H and Yang B: MDM2 promotes
epithelial-mesenchymal transition and metastasis of ovarian cancer
SKOV3 cells. Br J Cancer. 117:1192–1201. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Deben C, Deschoolmeester V, Lardon F,
Rolfo C and Pauwels P: TP53 and MDM2 genetic alterations in
non-small cell lung cancer: Evaluating their prognostic and
predictive value. Crit Rev Oncol Hematol. 99:63–73. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mizoshiri N, Shirai T, Terauchi R,
Tsuchida S, Mori Y, Hayashi D, Kishida T, Arai Y, Mazda O,
Nakanishi T and Kubo T: The tetraspanin CD81 mediates the growth
and metastases of human osteosarcoma. Cell Oncol (Dordr).
42:861–871. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Benassi MS, Gamberi G, Magagnoli G,
Molendini L, Ragazzini P, Merli M, Chiesa F, Balladelli A, Manfrini
M, Bertoni F, et al: Metalloproteinase expression and prognosis in
soft tissue sarcomas. Ann Oncol. 12:75–80. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wan L, Zhang L, Fan K, Cheng ZX, Sun QC
and Wang JJ: Knockdown of long noncoding RNA PCAT6 inhibits
proliferation and invasion in lung cancer cells. Oncol Res.
24:161–170. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Klein MJ and Siegal GP: Osteosarcoma:
Anatomic and histologic variants. Am J Clin Pathol. 125:555–581.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Miller BJ, Gao Y and Duchman KR:
Socioeconomic measures influence survival in osteosarcoma: An
analysis of the national cancer data base. Cancer Epidemiol.
49:112–117. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mirabello L, Troisi RJ and Savage SA:
Osteosarcoma incidence and survival rates from 1973 to 2004: Data
from the surveillance, epidemiology, and end results program.
Cancer. 115:1531–1543. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mirabello L, Troisi RJ and Savage SA:
International osteosarcoma incidence patterns in children and
adolescents, middle ages and elderly persons. Int J Cancer.
125:229–234. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Berger M, Fagioli F, Abate M, Riccardi R,
Prete A, Cozza R, Bertulli R, Podda M, Ferrari S and Luksch R:
Unusual sites of Ewing sarcoma (ES): A retrospective multicenter
30-year experience of the Italian association of pediatric
hematology and oncology (AIEOP) and Italian sarcoma group (ISG).
Eur J Cancer. 49:3658–3665. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xu R, Feng F, Yu X, Liu Z and Lao L:
LncRNA SNHG4 promotes tumour growth by sponging miR-224-3p and
predicts poor survival and recurrence in human osteosarcoma. Cell
Prolif. 51:e125152018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chang L, Guo R, Yuan Z, Shi H and Zhang D:
LncRNA HOTAIR regulates CCND1 and CCND2 expression by sponging
miR-206 in ovarian cancer. Cell Physiol Biochem. 49:1289–1303.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wu W, Gao H, Li X, Zhu Y, Peng S, Yu J,
Zhan G, Wang J, Liu N and Guo X: LncRNA TPT1-AS1 promotes
tumorigenesis and metastasis in epithelial ovarian cancer by
inducing TPT1 expression. Cancer Sci. 110:1587–1598. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhao H, Yu H, Zheng J, Ning N, Tang F,
Yang Y and Wang Y: Lowly-expressed lncRNA GAS5 facilitates
progression of ovarian cancer through targeting miR-196-5p and
thereby regulating HOXA5. Gynecol Oncol. 151:345–355. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li N and Zhan X and Zhan X: The lncRNA
SNHG3 regulates energy metabolism of ovarian cancer by an analysis
of mitochondrial proteomes. Gynecol Oncol. 150:343–354. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wan L, Zhang L, Fan K and Wang JJ:
Diagnostic significance of circulating long noncoding RNA PCAT6 in
patients with non-small cell lung cancer. Onco Targets Ther.
10:5695–5702. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shi Y, Lv C, Shi L and Tu G: MEG3 inhibits
proliferation and invasion and promotes apoptosis of human
osteosarcoma cells. Oncol Lett. 15:1917–1923. 2018.PubMed/NCBI
|
|
38
|
Wang B, Fang L, Zhao H, Xiang T and Wang
D: MDM2 inhibitor Nutlin-3a suppresses proliferation and promotes
apoptosis in osteosarcoma cells. Acta Biochim Biophys Sin
(Shanghai). 44:685–691. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang S, Zhao Y, Aguilar A, Bernard D and
Yang CY: Targeting the MDM2-p53 protein-protein interaction for new
cancer therapy: Progress and challenges. Cold Spring Harb Perspect
Med. 7:a0262452017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tovar C, Graves B, Packman K, Filipovic Z,
Higgins B, Xia M, Tardell C, Garrido R, Lee E, Kolinsky K, et al:
MDM2 small-molecule antagonist RG7112 activates p53 signaling and
regresses human tumors in preclinical cancer models. Cancer Res.
73:2587–2597. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang Y, Zeng X, Wang N, Zhao W, Zhang X,
Teng S, Zhang Y and Lu Z: Long noncoding RNA DANCR, working as a
competitive endogenous RNA, promotes ROCK1-mediated proliferation
and metastasis via decoying of miR-335-5p and miR-1972 in
osteosarcoma. Mol Cancer. 17:892018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhao W, Zhang D, Qin P, Zhang J, Cui X,
Gao J, Wang J and Li J: Long non-coding RNA EPIC1 inhibits
viability and invasion of osteosarcoma cells by promoting MEF2D
ubiquitylation. Int J Biol Macromol. 128:566–573. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Hu T, Fei Z, Su H, Xie R and Chen L:
Polydatin inhibits proliferation and promotes apoptosis of
doxorubicin-resistant osteosarcoma through LncRNA TUG1 mediated
suppression of Akt signaling. Toxicol Appl Pharmacol. 371:55–62.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Li Z, Yang L, Liu X, Nie Z and Luo J: Long
noncoding RNA MEG3 inhibits proliferation of chronic myeloid
leukemia cells by sponging microRNA21. Biomed Pharmacother.
104:181–192. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wang D and Hu Y: Long non-coding RNA PVT1
competitively binds MicroRNA-424-5p to regulate CARM1 in
radiosensitivity of non-small-cell lung cancer. Mol Ther Nucleic
Acids. 16:130–140. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhang Z, Zou G, Chen X, Lu W, Liu J, Zhai
S and Qiao G: Knockdown of lncRNA PVT1 inhibits vascular smooth
muscle cell apoptosis and extracellular matrix disruption in a
murine abdominal aortic aneurysm model. Mol Cells. 42:218–227.
2019.PubMed/NCBI
|
|
47
|
Finlay CA, Hinds PW and Levine AJ: The p53
proto-oncogene can act as a suppressor of transformation. Cell.
57:1083–1093. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Bieging KT, Mello SS and Attardi LD:
Unravelling mechanisms of p53-mediated tumour suppression. Nat Rev
Cancer. 14:359–370. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Wade M, Li YC and Wahl GM: MDM2, MDMX and
p53 in oncogenesis and cancer therapy. Nat Rev Cancer. 13:83–96.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Gunia S, Kakies C, Erbersdobler A,
Hakenberg OW, Koch S and May M: Expression of p53, p21 and cyclin
D1 in penile cancer: p53 predicts poor prognosis. J Clin Pathol.
65:232–236. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Li M, Li L, Zhang L, Hu W, Shen J, Xiao Z,
Wu X, Chan FL and Cho CH: 1,25-Dihydroxyvitamin D3 suppresses
gastric cancer cell growth through VDR- and mutant p53-mediated
induction of p21. Life Sci. 179:88–97. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Abolhasani M, Salarinejad S and Asgari M:
P53 and MDM2 over-expression and five-year survival of kidney
cancer patients undergoing radical nephrectomy-iranian experience.
Asian Pac J Cancer Prev. 16:5043–5047. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Wu D, Niu X, Tao J, Li P, Lu Q, Xu A, Chen
W and Wang Z: MicroRNA-379-5p plays a tumor-suppressive role in
human bladder cancer growth and metastasis by directly targeting
MDM2. Oncol Rep. 37:3502–3508. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Chaar I, Amara S, Khiari M, Ounissi D,
Dhraif M, Ben Hamida AE, Gharbi L, Mzabi S and Bouraoui S:
Relationship between MDM2 and p53 alterations in colorectal cancer
and their involvement and prognostic value in the Tunisian
population. Appl Immunohistochem Mol Morphol. 21:228–236.
2013.PubMed/NCBI
|
|
55
|
Liu Y, Wang X, Wang G, Yang Y, Yuan Y and
Ouyang L: The past, present and future of potential small-molecule
drugs targeting p53-MDM2/MDMX for cancer therapy. Eur J Med Chem.
176:92–104. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Cui LH, Xu HR, Yang W and Yu LJ: lncRNA
PCAT6 promotes non-small cell lung cancer cell proliferation,
migration and invasion through regulating miR-330-5p. Onco Targets
Ther. 11:7715–7724. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Wu H, Zou Q, He H, Liang Y, Lei M, Zhou Q,
Fan D and Shen L: Long non-coding RNA PCAT6 targets miR-204 to
modulate the chemoresistance of colorectal cancer cells to
5-fluorouracil-based treatment through HMGA2 signaling. Cancer Med.
8:2484–2495. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Xin Y, He X, Zhao W, Zhan M, Li Y, Xiao J,
He K and Lu L: LncRNA PCAT6 increased cholangiocarcinoma cell
proliferation and invasion via modulating miR-330-5p. Am J Transl
Res. 11:6185–6195. 2019.PubMed/NCBI
|
|
59
|
Zhang J, Liu M, Liu W and Wang W:
Ras-ERK1/2 signalling promotes the development of osteosarcoma
through regulation of H4K12ac through HAT1. Artif Cells Nanomed
Biotechnol. 47:1207–1215. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Chen W, Liu Q, Fu B, Liu K and Jiang W:
Overexpression of GRIM-19 accelerates radiation-induced
osteosarcoma cells apoptosis by p53 stabilization. Life Sci.
208:232–238. 2018. View Article : Google Scholar : PubMed/NCBI
|
